Clinical Trial Update: Arimidex in McCune Albright Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 trial of Arimidex (anastrozole) for McCune-Albright Syndrome has completed. The entry notes the study status as COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mccune-albright Syndrome

Drugs mentioned

• ARIMIDEX (anastrozole)

Snippet

Sponsor: AstraZeneca | Conditions: McCune-Albright Syndrome | Phase 2 | Status: COMPLETED